Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrence × Cabergoline × Clear all

Sponsor

Conditions

Pituitary Neoplasms 2 Pituitary ACTH Hypersecretion 2 Prostatic Neoplasms 1 Prolactinoma 1 Neuroendocrine Tumors 1 Neoplasms 1 Melanoma 1 Dumping Syndrome 1 Breast Neoplasms 1 Adrenocortical Hyperfunction 1 Acromegaly 1

Interventions

Cyclophosphamide 31 Dexamethasone 28 Cytarabine 20 fludarabine phosphate 18 Rituximab 18 Lenalidomide 16 Methotrexate 15 Bortezomib 15 fludarabine 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 pembrolizumab 12 Peripheral Blood Stem Cell Transplantation 12 Mycophenolic Acid 12 Etoposide 12 Melphalan 11 Gemcitabine 11 Filgrastim 11 Cyclosporine 11 Paclitaxel 10 pomalidomide 9 Carboplatin 9 Vincristine 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Busulfan 8 Brentuximab Vedotin 8 Bevacizumab 8 carfilzomib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡